123 related articles for article (PubMed ID: 36905338)
21. Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma.
Santambrogio R; Bruno S; Kluger MD; Costa M; Salceda J; Belli A; Laurent A; Barabino M; Opocher E; Azoulay D; Cherqui D
Dig Liver Dis; 2016 Feb; 48(2):189-96. PubMed ID: 26675381
[TBL] [Abstract][Full Text] [Related]
22. HabibTM 4X-assisted resection versus clamp-crush resection for hepatocellular carcinoma: a propensity-matching study.
Qiu J; Lu W; Yu N; Yang G; Li Y; Huang Z; Li J; Li K; Xu H; Chen S; Zeng X; Liu H
Oncotarget; 2017 Jan; 8(3):4218-4227. PubMed ID: 27965468
[TBL] [Abstract][Full Text] [Related]
23. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
24. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.
Takahara T; Wakabayashi G; Beppu T; Aihara A; Hasegawa K; Gotohda N; Hatano E; Tanahashi Y; Mizuguchi T; Kamiyama T; Ikeda T; Tanaka S; Taniai N; Baba H; Tanabe M; Kokudo N; Konishi M; Uemoto S; Sugioka A; Hirata K; Taketomi A; Maehara Y; Kubo S; Uchida E; Miyata H; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):721-7. PubMed ID: 26096910
[TBL] [Abstract][Full Text] [Related]
25. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study.
Hsiao CY; Hu RH; Ho CM; Wu YM; Lee PH; Ho MC
Am J Surg; 2020 Oct; 220(4):958-964. PubMed ID: 32247523
[TBL] [Abstract][Full Text] [Related]
26. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
27. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
[TBL] [Abstract][Full Text] [Related]
28. Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation and/or Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis.
Orimo T; Kamiyama T; Yokoo H; Wakayama K; Shimada S; Einama T; Kamachi H; Taketomi A
Dig Surg; 2018; 35(5):427-434. PubMed ID: 28903105
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
[TBL] [Abstract][Full Text] [Related]
30. Survival benefit of radiofrequency ablation for solitary (3-5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry.
Lee SH; Jin YJ; Lee JW
Medicine (Baltimore); 2017 Nov; 96(44):e8486. PubMed ID: 29095307
[TBL] [Abstract][Full Text] [Related]
31. Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
Zhuang BW; Li W; Wang W; Li B; Lu MD; Kuang M; Xie XH; Xie XY
Eur Radiol; 2021 Jul; 31(7):5379-5389. PubMed ID: 33404697
[TBL] [Abstract][Full Text] [Related]
32. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
33. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
[TBL] [Abstract][Full Text] [Related]
34. Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.
Andreou A; Struecker B; Raschzok N; Krenzien F; Haber P; Wabitsch S; Waldbaur C; Touet EM; Eichelberg AC; Atanasov G; Biebl M; Bahra M; Öllinger R; Schmelzle M; Pratschke J
Surg Oncol; 2018 Dec; 27(4):751-758. PubMed ID: 30449503
[TBL] [Abstract][Full Text] [Related]
35. Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study.
Qiu J; Zheng Y; Shen J; Zeng QA; Zou R; Liao Y; He W; Li Q; Chen G; Li B; Yuan Y
Surgery; 2015 Nov; 158(5):1235-43. PubMed ID: 25958066
[TBL] [Abstract][Full Text] [Related]
36. Improved outcomes with surgery compared to radiofrequency ablation in the treatment of resectable hepatocellular carcinoma.
Ruff SM; Khader A; Conte C; Kadison A; Sullivan J; Wang J; Zaidi R; Deutsch GB
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1397-1402. PubMed ID: 30985455
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
[TBL] [Abstract][Full Text] [Related]
38. Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection.
Di Sandro S; Benuzzi L; Lauterio A; Botta F; De Carlis R; Najjar M; Centonze L; Danieli M; Pezzoli I; Rampoldi A; Bagnardi V; De Carlis L
Eur J Surg Oncol; 2019 Sep; 45(9):1691-1699. PubMed ID: 31072620
[TBL] [Abstract][Full Text] [Related]
39. Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: a propensity score analysis and staging strategy.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD
J Gastroenterol Hepatol; 2012 Apr; 27(4):690-9. PubMed ID: 22436058
[TBL] [Abstract][Full Text] [Related]
40. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
